LETTER TO EDITORS Atherosclerosis in 2015: Hypotheses and Viewpoints. Our Comments, Assertions and the Realities

Authors

  • Faruk Erzengin Department of Cardiology, Previous Dean, University of Istanbul, Istanbul Medical Faculty, Istanbul, Turkey
  • Evren Buruk Program of Biomedical Technologies, University of Istanbul, Vocational School of Technical Sciences, Istanbul, Turkey

DOI:

https://doi.org/10.12970/2311-052X.2015.03.01.1

Keywords:

 Shrimp shells, protein, chitin, minerals, deproteinization, Aspergillus. niger, proteases, galactose, temperature, pH, moisture content.

Abstract

Formation of atherosclerotic and calcified plaque begins and grows up not only beneath the endothelium (intimae), but also in the adventitial subepithelium on the coronary arteries.

A new innovative combined drug (polypill) certainly releases, regresses and prevents of formation of the atherosclerotic and calcified plaque of arteries.

References

Fuster V. Epidemic of cardiovascular disease and stroke: The three main challenges. Circulation 1999; 99: 1132-7. http://dx.doi.org/10.1161/01.CIR.99.9.1132

Fuster V. Atherosclerosis, thrombosis, and vascular biology. Cecil Textbook of Medicine, Ed: Lee Goldman, Dennis Ausiello, 22nd Edition, Saunders, Philadelphia, Philadelphia 2004; pp. 383-400.

Lipid Study Group. Prevention of cardiovascular events and death with pravastatin in patient with coronary heart disease and abroad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Stud Group. N Eng J Me 1998; 339: 1349. http://dx.doi.org/10.1056/NEJM199811053391902

Falk E, Fuster V. Atherogenesis and its determinants. Hurst’s The Heart, Ed: Valentin Fuster, R. Wayne Alexander, Robert A. O’Rourke, Robert Roberts, Spencer B. King III, Hein J.J.Wellens. 10th edition, McGraw-Hıll, New York 2001; Vol. 1: pp. 1065-93.

Scicchitano P, Marzullo A, Ciccone MM. The role of intimal arterial calcification in the context of atherosclerotic plaque stability. Cytology and Histology 2014; 5(3): 1000e111.

Ross R. The biology of atherosclerosis. In: Topol E J, ed. Comprehensive Cardiovascular Medicine. Philadelphia: lippincott-Raven 1998; 13.

Iiyama K, Hajra L, Iiyama M, Li H. Patterns of vascular cell adhesion molecule-1 and intracellular adhesion molecule-1 expression in rabbit and Mouse atherosclerotic lesions and at site predisposed to lesion formation. Circ Res 1999; 85: 199- 207. http://dx.doi.org/10.1161/01.RES.85.2.199

Expert Dyslipidemia Panel of the International Atherosclerosis Society Panel members. An International Atherosclerosis Society Position Paper: global recommendations for the management of dyslipidemia—full report. J Clin Lipidol 2014; 8(1): 29-60. http://dx.doi.org/10.1016/j.jacl.2013.12.005

Lesckha S, Alkadhi H, Plass A, Desbiolles L, Grunenfelder J, Merincek B, Wildermuth S. Accuracy of MSCT coronary angiography with 64-slice technology: Firs experience. Eur Heart J 2005; 1482-1487. http://dx.doi.org/10.1093/eurheartj/ehi261

Erzengin F, Büyüköztürk K. Cardiac Imaging in Textbook of Internal Medicine, Ed: Kemalettin Büyüköztürk, Faruk Erzengin et al. Nobel, Istanbul, 2007; 1623-1644.

Westendorp RG, Assendelft WJ, Elzen WP, Cessie S, Gussekloo J. Use of Framingham risk and new biomarkers to predict cardiovascular mortality in older people: Population base observational cohort study. BMJ 2009; 338: a 3083.

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adult (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143- 421.

Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menoti A, De Backer G. Estimation of ten year risk of fatal cardiovascular disease in Europe: The SCORE Project. European Heart Journal 2003; 290: 898-904. http://dx.doi.org/10.1016/S0195-668X(03)00114-3

Scicchitano P, Carbonara S, Ricci G, et al. Review: HCN channels and heart rate. Molecules 2012; 17: 4225-35. http://dx.doi.org/10.3390/molecules17044225

Scicchitano P, Cortese F, Ricci G, et al. Ivabradine, coronary artery disease, and heart failure: beyond rhythm control. Drug Design, Development and Therapy 2014; 8: 689-700.

Hendel RC, Patel MR, Kramer CM, Poon M. ACC/ACR/SCMR/ASNC /NASCI/ SCAI/SIR Apropriateness Criteria for Cardiac Computed Tomography and Cardiac Magnetic Resonance Imaging. Journal of the American College of Cardiology 2006; 48(7): 1-23.

Achenbach S, Daniel WG. Computed Tomography of the Heart. Braunwald’s Heart Disease, 7th edition, Elsevier Saunders, Pensilvania, USA 2005; 285-7.

Higgins CB, de Roos A. MRI and CT of the Cardiovascular system. Lipincor &Williams and Wilkins, USA and the Netherlands 2006.

Achenbach S, Moselewski F, Ropers D, Ferencik M, Hoffmann U, MacNeill B, Pohle K, Baum U, Anders K, Jang IK, Daniel WG, Brady TJ. Detection of calcified and noncalcified coronary atherosclerotic plaque by contrastenhanced, submillimeter multidetector spiral computed tomography: a segment-based comparison with intravscular ultrasound. Circulation 2004; 109: 14-17. http://dx.doi.org/10.1161/01.CIR.0000111517.69230.0F

Sangiorgy G, Rumberg J A,Severson A, et al. Arterial calcificationand not lumen stenosis is highly correlated with atherosclerotic plaqueburden in humans: A histologic study of 723 coronary artery segments using nondecalcifying methodology. J Am Coll Cardiol 1998; 31: 126-33. http://dx.doi.org/10.1016/S0735-1097(97)00443-9

Mintz GS, Pichard AD, Pompa JJ, et al. Determinants and correlates of target lesions calcium in coronary artery disease: A clinicali angiographic and intravascular ultasoun study. J Am Coll Cardiol 1997; 29: 268-274. http://dx.doi.org/10.1016/S0735-1097(96)00479-2

Yönal , Banzagch M, Özcan M, Adalet K, Erzengin F. Cardiac Computed Tomography; The Unique Noninvasive Method For The Detection Of Coronary Atherosclerotic Plaque Morphology And For The Diagnosis Of Silent Ischemia, Lumen Narrowing Calcification Of Adventitia: With Two Case Reports. The Heart Surgery Forum. A Cardiothoracic Multimedia Journal 2009; 12(Supl.1): 69-70.

Erzengin F. Adventitial Calcification: Surprise Location. Atherosclerotic and calcified plaques begin and grow up not only beneath the endothelium, but also on the adventitia. 78th European Atherosclerosis Society Congress (78th EAS Congress), Hamburg, Germany 2010; 20-23.

Erzengin F. Adventitial (Erzengin’s) Atherosclrerocalcification: Surprise Location. Atherosclerotic and calcified plaques begin and grow up not only beneath the endothelium, but also on the adventitia. The 3th World Medıcıne Congres n abstract book, Page 4 September 20- 23, 2010 /Nalchık-Russıa.

Erzengin F. Adventitial arherosclerocalcifications: A new surprise location, In Abstract book, 7th Congress of update in Cardiology and Cardiovascular Surgery in association with TCT Mediterranean 24-27th March, 2011/Antalya-Turkey.

Bissen EA. Plaque Adventitia: Service Hatch or Battleground? 79th EAS Congress Gothenburg, Sweden, June 26-29, 2011.

Erzengin F. Erzengin’s Polypıll: An additinal medical treatment of the atherosclerocalcifications. The 4th international medical conference on ‘‘advances incontemporary medıcıne’’ 7-8 October, 2011, Istanbul.

Erzengin F. Letter to the editor: Adventıtıal atherosclerosıs and calcıfıcatıons: Cardiovascular Sciences, Accepted for press (07.06.2010- Nm:18915).

Erzengin F. Erzengin’s Polypill: An additional and new medical treatment of atherosclerocalcifications. International Journal of Cardiology 2012; 147: 111-2.

Efe D, Aygun F. Assessment of the Relationship Between Non-alcoholic Fatty Liver Disease and CAD using MSCT. Arq Bras Cardiol 2014; 102(1): 10-18.

Lee S, Chang H, Sung J, et al. The Impact of Obesity on Subclinical Coronary Atherosclerosis According to the Risk of Cardiovascular Disease. Obesity 2014; 22(7): 1762-8. http://dx.doi.org/10.1002/oby.20760

LIacobellis G, Ribaudo MC, Zappaterrano A, Iannucci CV, Leonetti F. Relation between epicardial adipose tissue and left ventricular mass. Am.J Cardiol 2004; 94: 1084-7.

Erzengin F. Adventitial (Erzengin’s) Atherosclerocalcification: Surprise Location and a New Concept of the Formation of Atherosclerocalcifications in 2013. The Tip of the Iceberg and a New Innovative Current Drugs for Certain Solution with the Erzengin’s Polypill. Journal of cardiology and Therapeutics 2013; 1(2): 37-50.

Erzengin F. New Hypotheses and Viewpoints for Atherosclerosis in 2013. General Medicine 2: Open Access 2014; 1(1): 1-11. http://dx.doi.org/10.4172/2327-5146.1000130

Ciccone MM, Cortese F, Gesualdo M, et al. Review: Dietary intake of caretenoids and their antioxidant and anti- inflammatory effects in cardiovascular care. Mediators and Inflammation 2013; 2013: 11. http://dx.doi.org/10.1155/2013/782137

Scicchitano P, Cameli M, Maiello M, et al. Gruppo di Studio Ipertensione, Prevenzione e Riabilitazione, Società Italiana di Cardiologia. Journal of Functional Foods 2014; 6: 11-32. http://dx.doi.org/10.1016/j.jff.2013.12.006

Downloads

Published

2015-08-03

Issue

Section

Articles